Clinical trial
A Prospective Randomized Double Blind Placebo Controlled Phase II Trial of Intra-coronary Infusion of AMR-001, a Bone Marrow Derived Autologous CD34+ Selected Cell Product, in Patients With Acute Myocardial Infarction.
NCT01495364 is registered in ClinicalTrials.gov with Lisata Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Randomized Double Blind Placebo Controlled Phase II Trial of Intra-coronary Infusion of AMR-001, a Bone Marrow Derived Autologous CD34+ Selected Cell Product, in Patients With Acute Myocardial Infarction.
- Lead sponsor
- Lisata Therapeutics, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 31, 2011
- Completion date
- April 30, 2016
- Enrollment
- 195 (actual)
- Sites
- 58
Conditions
As the registry lists them; a condition with its own page is linked.
st segment elevation myocardial infarction